Nicol F, Nir S, Szoka F C
University of California, School of Pharmacy, Departments of Biopharmaceutics and Pharmaceutical Chemistry, San Francisco, California 94143-0446, USA.
Biophys J. 1999 Apr;76(4):2121-41. doi: 10.1016/S0006-3495(99)77368-6.
We determined the orientation of a biotinylated version of the pore-forming peptide GALA (WEAALAEALAEALAEHLAEALAEALEALAA) at pH 5.0 in large unilamellar phosphatidylcholine vesicles, using the enhancement of BODIPY-avidin fluorescence subsequent to its irreversible binding to a biotin moiety. GALA and its variants were biotinylated at the N- or C-terminus. BODIPY-avidin was either added externally or was pre-encapsulated in vesicles to assess the fraction of liposome-bound biotinylated GALA that exposed its labeled terminus to the external or internal side of the bilayer, respectively. Under conditions where most of the membrane-bound peptides were involved in transmembrane aggregates and formed aqueous pores (at a lipid/bound peptide molar ratio of 2500/1), the head-to-tail (N- to C-terminus) orientation of the membrane-inserted peptides was such that 3/4 of the peptides exposed their N-terminus on the inside of the vesicle and their C-terminus on the outside. Under conditions resulting in reduced pore formation (at higher lipid/peptide molar ratios), we observed an increase in the fraction of GALA termini exposed to the outside of the vesicle. These results are consistent with a model (Parente et al., Biochemistry, 29:8720, 1990) that requires a critical number of peptides (M) in an aggregate to form a transbilayer structure. When the peptides form an aggregate of size i, with i < M = 4 to 6, the orientation of the peptides is mostly parallel to the membrane surface, such that both termini of the biotinylated peptide are exposed to external BODIPY-avidin. This BODIPY-avidin/biotin binding assay should be useful to determine the orientation of other membrane-interacting molecules.
我们利用不可逆结合生物素部分后BODIPY-抗生物素蛋白荧光增强的方法,确定了pH 5.0条件下,形成孔道的肽GALA(WEAALAEALAEALAEHLAEALAEALEALAA)的生物素化版本在大单层磷脂酰胆碱囊泡中的取向。GALA及其变体在N端或C端进行了生物素化。BODIPY-抗生物素蛋白要么从外部添加,要么预先包封在囊泡中,以分别评估脂质体结合的生物素化GALA中,将其标记末端暴露于双层膜外侧或内侧的比例。在大多数膜结合肽参与跨膜聚集体并形成水相孔道的条件下(脂质/结合肽摩尔比为2500/1),插入膜中的肽的头对尾(N端到C端)取向使得3/4的肽将其N端暴露于囊泡内部,C端暴露于外部。在导致孔道形成减少的条件下(更高的脂质/肽摩尔比),我们观察到暴露于囊泡外部的GALA末端比例增加。这些结果与一个模型(Parente等人,《生物化学》,29:8720,1990)一致,该模型要求聚集体中存在关键数量的肽(M)以形成跨双层结构。当肽形成大小为i的聚集体,且i < M = 4至6时,肽的取向大多平行于膜表面,使得生物素化肽的两个末端都暴露于外部的BODIPY-抗生物素蛋白。这种BODIPY-抗生物素蛋白/生物素结合测定法对于确定其他膜相互作用分子的取向应该是有用的。